Dhanvantri Jeevan Rekha share price
BSE: 531043Healthcare ServicesSmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹22.00.
28 Oct: open ₹22.00, high ₹22.00, low ₹21.01
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9.02 Cr4,669th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.86
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 596
Results
Standalone; ₹ crore.Dhanvantri Jeevan Rekha quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +49.9%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹7.80 Crup 7.73%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹0.18 Crdown 40.00%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 2.3%
Revenue by quarter
Net profit by quarter, a loss in red
- Net profit
- Loss
The quarters either side of a change of basis do not compare. From the quarter to Mar 2026, the company's revenue for the year to Mar 2026, ₹26 Cr, differs from its quarters added, ₹31 Cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.4 | 5.7 | 5.8 | 5.5 | 11.4 | 7.3 | 7.2 | 7.8 |
| Net profit | 0.2 | 0.2 | 0.0 | 0.1 | −0.1 | 0.2 | 0.3 | 0.2 |
| Net margin | 3.1% | 2.6% | 0.5% | 1.1% | −0.7% | 2.3% | 4.1% | 2.3% |
Year to Mar 2026, against the year before
- Revenue
- ₹26 Cr
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.40 Crdown 21.57%
- Net margin
- 1.5%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
The years either side of a change of basis do not compare. From the year to Mar 2026, the company's revenue for that year, ₹26 Cr, differs from its quarters added, ₹31 Cr.
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.2 | 13.8 | 16.9 | 18.2 | 9.8 | 16.8 | 17.7 | 20.5 | 22.7 | 25.9 |
| Net profit | 0.6 | 0.7 | 0.0 | −0.3 | −1.4 | 0.5 | −0.2 | 0.2 | 0.5 | 0.4 |
| Net margin | 4.9% | 5.2% | 0.3% | −1.5% | −14.6% | 2.9% | −1.2% | 0.8% | 2.3% | 1.5% |
Business segments
In the year to Mar 2026 the company reports one business segment, HOSPITAL AND DIAGNOSTIC CENTRE, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the year to Mar 2026: days before it are of the company before the change.Dhanvantri Jeevan Rekha PE ratio and valuation
At or below today's level on 59% of 1,101 trading days over the last 5 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +21.7% | −21.6% | +55.2% | 0.0% |
| 3 years | +24.6% | – | – | 0.0% |
| 5 years | +27.5% | – | – | 0.0% |
Dhanvantri Jeevan Rekha competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Dhanvantri Jeevan Rekha in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Dhanvantri Jeevan Rekha is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Nidan Laboratories and HealthcareNIDAN | 18 | 12.00 | 0.26 | +4.1% | −23.8% | 2.2% | – | 0.00% |
 Transgene BiotekTRABI | 18 | – | 2.13 | −15.0% | – | −17.5% | −2.6% | 0.00% |
 Dolphin Medical ServicesDOLPHMED | 10 | – | 1.02 | – | – | – | – | 0.00% |
 Family Care HospitalsFAMILYCARE | 10 | – | 1.02 | −93.9% | – | −73.4% | −27.5% | 0.00% |
 Boston Commerce531458 | 8 | – | – | – | – | – | – | 0.00% |
 Looks Health ServicesLOOKS | 8 | 317.19 | 0.51 | −5.1% | −69.0% | 0.2% | 0.2% | 0.00% |
 Clinitech LaboratoryCTLLAB | 7 | 16.85 | 0.76 | – | – | 4.6% | – | 0.00% |
 Dr Lalchandani LabsDLCL | 6 | 96.16 | 0.43 | −6.0% | −84.8% | 0.5% | – | 0.00% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dhanvantri Jeevan Rekha dividend history
| Ex-date | Type | Per share |
|---|---|---|
| 15 Sep 2011 | Final | ₹0.40 |
| 11 Sep 2008 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹0.40 |
Latest announcements
Routine notices left out.Dhanvantri Jeevan Rekha announcements
Sep 2026
5 Sep · Reg. 34 (1) Annual Report.
Aug 2026
27 Aug · Meeting
27 Aug · Meeting
27 Aug · Board meeting
Dhanvantri Jeevan Rekha share price by year
Each calendar year to 2025.Dhanvantri Jeevan Rekha share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 25.04 | +11.9% | 35.85 | 16.75 |
| 2024 | 22.37 | +62.7% | 27.20 | 13.62 |
| 2023 | 13.75 | +2.3% | 15.45 | 10.51 |
| 2022 | 13.44 | +4.7% | 20.83 | 9.56 |
| 2021 | 12.84 | +151.8% | 12.84 | 5.00 |
| 2020 | 5.10 | −41.0% | 8.56 | 4.34 |
| 2019 | 8.65 | −53.2% | 18.50 | 8.65 |
| 2018 | 18.50 | −39.3% | 35.40 | 17.80 |
| 2017 | 30.50 | −14.0% | 61.70 | 30.50 |
| 2016 | 35.45 | +76.4% | 35.45 | 20.50 |
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 2 |
| 26 Oct 2026 | 22.39 | 22.40 | 22.39 | 22.39 | 22.39 | 1,002 |
| 23 Oct 2026 | 23.70 | 23.70 | 23.56 | 23.56 | 23.63 | 2,001 |
| 21 Oct 2026 | 23.50 | 24.80 | 23.50 | 24.80 | 24.06 | 126 |
| 19 Oct 2026 | 23.75 | 23.75 | 23.75 | 23.75 | 23.75 | 46 |
| 16 Oct 2026 | 25.00 | 25.00 | 23.75 | 23.75 | – | 47 |
| 15 Oct 2026 | 24.95 | 24.95 | 24.95 | 24.95 | 24.95 | 11 |
| 14 Oct 2026 | 24.95 | 24.95 | 24.95 | 24.95 | 24.95 | 9 |
| 13 Oct 2026 | 22.00 | 23.80 | 22.00 | 23.80 | 22.80 | 112 |
Company details
- BSE code
- 531043
- ISIN
- INE239F01015
- Industry
- Healthcare Services
- Website
- www.djrl.org.in
- CIN
- L85110UP1993PLC015458
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1993
- Registered office
- Number One, Saket, Meerut 250003, Uttar Pradesh
- Share registrar
- Beetal Financial & Computer Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments